Arcus Biosciences (RCUS) Receivables - Other (2017 - 2026)
Arcus Biosciences (RCUS) reported Receivables - Other of $36 million for Q2 2026, up 140.0% from $15 million a year earlier.
Powered by 
Analysis
Arcus Biosciences (RCUS) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences posted Receivables - Other of $11 million, down 45.0% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
- By year, Receivables - Other came in at $20 million in FY2024 (-47.4%), $38 million in FY2023, -$704 million in FY2022 and $745 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Receivables - Other since Q4 2023.
- Year over year, Receivables - Other gained in 1 of the last eight quarters, with an average decline of 29.6%.
- The high point for year-over-year Receivables - Other in five years was Q4 2023 (growth of 171.2%); the low point was Q1 2026 (a decline of 80.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3 million (Q1 2026), $11 million (Q4 2025) and $11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 28.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | 38.00 Mn |
| Sep 30, 2023 | 52.00 Mn |
| Jun 30, 2023 | 34.00 Mn |
| Mar 31, 2023 | 33.00 Mn |
| Dec 31, 2022 | 14.01 Mn |
| Sep 30, 2022 | 27.29 Mn |
| Jun 30, 2022 | 35.83 Mn |
| Mar 31, 2022 | -715.00 Mn |
| Dec 31, 2021 | 17.33 Mn |
| Sep 30, 2021 | 871,000.00 |
API Access
Arcus Biosciences Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();